Refresh

Mesco Pharmaceuticals Ltd. - Research Center

500274 MESPHAR-B Group (ZP) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 21 Mar ' 20 Mar ' 19 Mar ' 18 Mar ' 17
Income

Operating income

- - - - -
Expenses

Material consumed

- - - - -

Manufacturing expenses

- - - - -

Personnel expenses

- - - 0.03 0.04

Selling expenses

- 0.01 0.01 0.01 -

Adminstrative expenses

- 0.09 0.40 0.05 0.22

Expenses capitalised

- - - - -

Cost of sales

- 0.10 0.41 0.09 0.26

Operating profit

- -0.10 -0.41 -0.09 -0.26

Other recurring income

- - - - -

Adjusted PBDIT

- - - -0.09 -0.26

Financial expenses

- - - - -

Depreciation

- - - - -

Other write offs

- - - - -

Adjusted PBT

- -0.10 -0.41 -0.09 -0.26

Tax charges

- - - - -

Adjusted PAT

- - - -0.09 -0.26

Non recurring items

- - - - -

Other non cash adjustments

- - - - -

Reported net profit

- -0.10 -0.41 -0.09 -0.26

Earnigs before appropriation

-89.73 -89.73 -89.63 -89.22 -89.13

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

-89.73 -89.73 -89.63 -89.22 -89.13
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com